To explore the influences of HYAL3 on the OS of BLCA patients, we constructed Kaplan–Meier survival curves according to the expression levels of HYAL3 to investigate whether HYAL3 expression affected the outcomes of patients with BLCA. The gene discussed is HYAL3; the disease is bladder transitional cell carcinoma.